Serum institute of india seeks approval for covishield from EU


In a few weeks, the Serum Institute of India expects European drug authorities to approve Covishield, the Covid-19 injection it produces in collaboration with AstraZeneca, allowing it to be added to the region’s ‘Green Pass’ list.
Serum’s Chief Executive Officer Adar Poonawalla said at the India Global Forum on Wednesday that the world’s largest vaccine producer is “very optimistic” that the European Medicines Agency would approve the injection in a month.
They were leaving Serum-made Covishield off the so-called ‘Green Pass’ list while including Vaxzevria – a European brand name for the same vaccine – as part of the European Union’s vaccine passport initiative sparked outrage in India because it could result in Indian travelers being denied entry despite having received their vaccinations. Nations are rushing to vaccinate their citizens, rebuild their economy, and keep emerging viral types out of their borders.
“It’s not even a debate,” Poonawalla added. “The reason it was identified is that if we don’t fix it now when India is removed from the red list and individuals want to travel, they should not be denied entry into a country just because they have a Covishield certificate,” says the official.
According to the latest health ministry data, India has given out 336 million Covid dosages. Bloomberg’s Vaccine Tracker reveals that just 4.3 percent of the country’s population has been fully immunizing against the virus.


Please enter your comment!
Please enter your name here

Enable Google Transliteration.(To type in English, press Ctrl+g)